Brief: C-Rad And Accuray Sign Agreement To Enhance Radixact System Breast Cancer Treatment Capabilities
Oct 4 (Reuters) - Accuray Inc ARAY.O :
* C-RAD AND ACCURAY SIGN AGREEMENT TO ENHANCE RADIXACT®
SYSTEM
BREAST CANCER TREATMENT CAPABILITIES
* EVELOPMENT WORK WILL COMMENCE BEFORE END OF 2021
* FIRST INTERFACE LINKING CATALYST TECHNOLOGY AND RADIXACT
SYSTEM
ANTICIPATED TO BE MADE AVAILABLE IN MID-2022.
Source text for Eikon: ID:nMFN6wrBRQ
Further company coverage: ARAY.O
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))